Provenge and Asymptomatic Prostate Cancer

Links shared publicly online about this topic

PROVENGE

highpointregional.com — “High Point Regional Health System. A private not-for-profit healthcare system in the North Carolina Piedmont Triad treating cancer, bariatric gastric bypass surgery, addiction, women's health, heart problems and much more. High Point Regional Hospital is 1 of only 4 in NC with Magnet Status.View full resource at highpointregional.com

  • View Related
  • Share

Most Recently Shared on May 26, 2011 at 5:51 pm By:

Provenge approved for the treatment of advanced prostate cancer - ONA

oncologynurseadvisor.com — “Dendreon announced the approval of Provenge (sipuleucel-T suspension for intravenous infusion) for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC).View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on April 29, 2010 at 8:08 pm By:

Provenge approved for the treatment of advanced prostate cancer - MPR

empr.com — “Dendreon announced the approval of Provenge (sipuleucel-T suspension for intravenous infusion) for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on April 29, 2010 at 7:52 pm By:

eMPR MPR Medical Publisher

MPR News: Provenge approved for the treatment of advanced prostate cancer: Dendreon announced the approval of Prov... http://bit.ly/cF1kYS

2 years ago...

Provenge fights prostate cancer

prostate-report.org — “Provenge fights prostate cancerView full resource at prostate-report.org

  • View Related
  • Share

Most Recently Shared on April 26, 2011 at 7:32 pm By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

Provenge fights prostate cancer: Most vaccines are for people who don’t want to get a future illness. Provenge i... http://bit.ly/fwBMJJ

1 year ago...

FDA Approves Provenge - a Cellular Immunotherapy for Men With Advanced Prostate Cancer

drugs.com — “Provenge (sipuleucel-T) is used to treat advanced prostate cancer. Includes Provenge side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 29, 2010 at 10:41 pm By:

drugscom Drugs.com Health Site

FDA Approves Provenge - a Cellular Immunotherapy for Men With Advanced Prostate Cancer - http://bit.ly/9KHZDo

2 years ago...

Provenge, a new prostate cancer treatment

prostate-report.org — “Provenge, a new prostate cancer treatmentView full resource at prostate-report.org

  • View Related
  • Share

Most Recently Shared on July 12, 2011 at 5:49 pm By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

Provenge, a new prostate cancer treatment: Provenge therapy is addressed to patients with prostate cancer who ha... http://bit.ly/o5h5qz

11 months ago...

FDA OKs Provenge for Prostate Cancer Therapy

webmd.com — “The FDA has approved Provenge, Dendreon Corp.'s individualizedView full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on April 29, 2010 at 6:44 pm By:

WebMD_News WebMD_News Health News

FDA OKs Provenge for Prostate Cancer Therapy: The FDA has approved Provenge, Dendreon Corp.'s individualized "vacc... http://bit.ly/cpm5I5

2 years ago...

Provenge a big hope for prostate cancer patients

prostate-report.org — “Provenge a big hope for prostate cancer patientsView full resource at prostate-report.org

  • View Related
  • Share

Most Recently Shared on November 16, 2010 at 8:32 pm By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

Provenge a big hope for prostate cancer patients: Researchers at the University of California San Francisco say ... http://bit.ly/cDqsk7

2 years ago...

No Additional Hearing at the FDA for Provenge :: Advanced Prostate Cancer

advancedprostatecancer.net — “No Additional Hearing at the FDA for Provenge :: Advanced Prostate CancerView full resource at advancedprostatecancer.net

  • View Related
  • Share

Most Recently Shared on March 3, 2010 at 4:46 pm By:

prostatecancer_ Prostate Cancer Support

No Additional Hearing at the FDA for Provenge :: Advanced Prostate ... http://bit.ly/dk0EIo

2 years ago...

Provenge Vaccine - The Latest Prostate Cancer Treatment Option

menshealth.suite101.com — “Dendreon's Provenge vaccine is the latest prostate cancer treatment option that will be available for advanced-stage patients, following recent FDA approvalView full resource at menshealth.suite101.com

  • View Related
  • Share

Most Recently Shared on May 8, 2010 at 1:46 am By:

HealthPassion HealthPassion Health News

Latest Prostate Cancer Treatment Option - Provenge Vaccine: Dendreon's Provenge vaccine is the latest prostate can... http://bit.ly/bjUz8a

2 years ago...

Provenge Approved for Advanced Prostate Cancer - Yahoo! News

news.yahoo.com — “THURSDAY, April 29 (HealthDay News) -- Provenge (sipuleucel-T), a therapy designed to boost the immune system's ability to combat prostate cancer, has been approved by the U.S. Food and Drug Administration.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on April 30, 2010 at 12:10 am By:

prostatecancer_ Prostate Cancer Support

Provenge Approved for Advanced Prostate Cancer - Yahoo! News http://bit.ly/bTgMC0

2 years ago...

PROVENGE - New Product Releases - MPR

empr.com — “Asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone-refractory) prostate cancer.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 29, 2010 at 1:53 pm By:

eMPR MPR Medical Publisher

MPR News: PROVENGE: Sipuleucel-T (autologous CD54+ cells activated with PAP-GM-CSF); minimum 50 million cells/dose... http://bit.ly/d95VRX

2 years ago...

FDA Approves Prostate Cancer Drug Provenge - CBS News

cbsnews.com — “Drug Manufacturer Dendreon Says Drug Treats Prostrate Cancer That Spreads Elsewhere in the BodyView full resource at cbsnews.com

  • View Related
  • Share

Most Recently Shared on May 5, 2010 at 3:04 pm By:

prostatecancer_ Prostate Cancer Support

FDA Approves Prostate Cancer Drug Provenge CBS News http://bit.ly/d6rtDj

2 years ago...

ALERT: PROVENGE Receives FDA Approval for Advanced Prostate Cancer Treatment | MediNEWS.Direct!

medinewsdirect.com — “The U.S. Food and Drug Administration (FDA) has granted approval for PROVENGE (sipuleucel-T | Dendreon Corporation) for treating asymptomatic or minimallyView full resource at medinewsdirect.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 11:51 am By:

prostatecancer_ Prostate Cancer Support

ALERT: PROVENGE Receives FDA Approval for Advanced Prostate Cancer Treatment http://bit.ly/aXzolb

2 years ago...

Prostate cancer: Provenge gets Medicare coverage - latimes.com

latimes.com — “The Centers for Medicare and Medicaid said it would begin to cover Provenge for advanced prostate cancer -- and that it will continue paying for Avastin.View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 6:33 pm By:

LATimeshealth LA Times Health News Health News

Prostate cancer treatment Provenge to be covered by Medicare, as is Avastin http://lat.ms/mTpJZX

11 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • HPRHS

    High Point Regional

    High Point Regional Health System provides exceptional health services to the people of our region.

    View Profile

  • ONAcom

    OncologyNurseAdvisor

    Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.

    View Profile

  • eMPR

    MPR

    eMPR.com provides up-to-date, concise drug information at the point-of-care.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390